Boston Scientific EPS - Earnings per Share 2010-2023 | BSX
- Boston Scientific EPS for the quarter ending December 31, 2023 was $0.34, a 277.78% increase year-over-year.
- Boston Scientific EPS for the twelve months ending December 31, 2023 was $1.07, a 137.78% increase year-over-year.
- Boston Scientific 2023 annual EPS was $1.07, a 137.78% increase from 2022.
- Boston Scientific 2022 annual EPS was $0.45, a 34.78% decline from 2021.
- Boston Scientific 2021 annual EPS was $0.69, a 962.5% decline from 2020.
Boston Scientific Annual EPS | |
---|---|
2023 | $1.07 |
2022 | $0.45 |
2021 | $0.69 |
2020 | $-0.08 |
2019 | $3.33 |
2018 | $1.19 |
2017 | $0.08 |
2016 | $0.25 |
2015 | $-0.18 |
2014 | $-0.09 |
2013 | $-0.09 |
2012 | $-2.89 |
2011 | $0.29 |
2010 | $-0.70 |
2009 | $-0.68 |
Boston Scientific Quarterly EPS | |
---|---|
2023-12-31 | $0.34 |
2023-09-30 | $0.34 |
2023-06-30 | $0.18 |
2023-03-31 | $0.21 |
2022-12-31 | $0.09 |
2022-09-30 | $0.12 |
2022-06-30 | $0.17 |
2022-03-31 | $0.07 |
2021-12-31 | $0.06 |
2021-09-30 | $0.28 |
2021-06-30 | $0.12 |
2021-03-31 | $0.23 |
2020-12-31 | $0.14 |
2020-09-30 | $-0.12 |
2020-06-30 | $-0.11 |
2020-03-31 | $0.01 |
2019-12-31 | $2.83 |
2019-09-30 | $0.09 |
2019-06-30 | $0.11 |
2019-03-31 | $0.30 |
2018-12-31 | $0.27 |
2018-09-30 | $0.31 |
2018-06-30 | $0.40 |
2018-03-31 | $0.21 |
2017-12-31 | $-0.44 |
2017-09-30 | $0.20 |
2017-06-30 | $0.11 |
2017-03-31 | $0.21 |
2016-12-31 | $0.08 |
2016-09-30 | $0.17 |
2016-06-30 | $-0.15 |
2016-03-31 | $0.15 |
2015-12-31 | $-0.11 |
2015-09-30 | $-0.15 |
2015-06-30 | $0.08 |
2015-03-31 | $0.00 |
2014-12-31 | $-0.22 |
2014-09-30 | $0.03 |
2014-06-30 | $0.00 |
2014-03-31 | $0.10 |
2013-12-31 | $0.07 |
2013-09-30 | $0.00 |
2013-06-30 | $0.10 |
2013-03-31 | $-0.26 |
2012-12-31 | $0.02 |
2012-09-30 | $-0.48 |
2012-06-30 | $-2.51 |
2012-03-31 | $0.08 |
2011-12-31 | $0.07 |
2011-09-30 | $0.09 |
2011-06-30 | $0.10 |
2011-03-31 | $0.03 |
2010-12-31 | $0.17 |
2010-09-30 | $0.12 |
2010-06-30 | $0.06 |
2010-03-31 | $-1.05 |
2009-12-31 | $-0.71 |
2009-09-30 | $-0.06 |
2009-06-30 | $0.10 |
2009-03-31 | $-0.01 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $109.372B | $14.240B |
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $182.435B | 23.89 |
Stryker (SYK) | United States | $127.230B | 30.47 |
Medtronic (MDT) | Ireland | $113.715B | 16.10 |
EssilorLuxottica (ESLOY) | France | $101.565B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.132B | 0.00 |
Haleon (HLN) | United Kingdom | $38.219B | 27.90 |
ResMed (RMD) | United States | $32.315B | 30.34 |
Terumo (TRUMY) | Japan | $26.460B | 37.37 |
Koninklijke Philips (PHG) | Netherlands | $25.501B | 19.75 |
Zimmer Biomet Holdings (ZBH) | United States | $24.940B | 15.93 |
Baxter (BAX) | United States | $17.922B | 12.74 |
Insulet (PODD) | United States | $12.984B | 57.57 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.301B | 0.00 |
Demant (WILYY) | Denmark | $10.234B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.436B | 27.59 |
BellRing Brands (BRBR) | United States | $7.595B | 35.72 |
Lantheus Holdings (LNTH) | United States | $5.621B | 14.01 |
Haemonetics (HAE) | United States | $4.815B | 23.82 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.103B | 12.44 |
Envista Holdings (NVST) | United States | $3.288B | 13.57 |
Prestige Consumer Healthcare (PBH) | United States | $3.244B | 15.44 |
QuidelOrtho (QDEL) | United States | $2.946B | 16.35 |
Neogen (NEOG) | United States | $2.905B | 27.94 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.791B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.760B | 54.67 |
TG Therapeutics (TGTX) | United States | $2.692B | 75.74 |
ICU Medical (ICUI) | United States | $2.589B | 22.85 |
Agios Pharmaceuticals (AGIO) | United States | $1.987B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.828B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.744B | 51.10 |
Warby Parker (WRBY) | United States | $1.600B | 0.00 |
InMode (INMD) | Israel | $1.565B | 8.32 |
Owens & Minor (OMI) | United States | $1.462B | 12.74 |
AdaptHealth (AHCO) | United States | $1.312B | 9.75 |
National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
AtriCure (ATRC) | United States | $1.077B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
Canopy Growth (CGC) | Canada | $0.926B | 0.00 |
Evolus (EOLS) | United States | $0.858B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.767B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.728B | 15.50 |
Quanterix (QTRX) | United States | $0.664B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.623B | 14.65 |
Valneva SE (VALN) | France | $0.614B | 0.00 |
PetIQ (PETQ) | United States | $0.583B | 19.05 |
TerrAscend (TSNDF) | Canada | $0.525B | 0.00 |
Jin Medical (ZJYL) | China | $0.507B | 0.00 |
Surmodics (SRDX) | United States | $0.486B | 30.43 |
ZimVie (ZIMV) | United States | $0.463B | 39.49 |
Aurora Cannabis (ACB) | Canada | $0.415B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.387B | 12.45 |
Cerus (CERS) | United States | $0.362B | 0.00 |
Biote (BTMD) | United States | $0.362B | 8.34 |
Zynex (ZYXI) | United States | $0.350B | 47.83 |
MacroGenics (MGNX) | United States | $0.321B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.274B | 27.19 |
Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.249B | 15.66 |
Ayr Wellness (AYRWF) | United States | $0.222B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.210B | 0.00 |
Veru (VERU) | United States | $0.201B | 0.00 |
Omeros (OMER) | United States | $0.192B | 0.00 |
High Tide (HITI) | Canada | $0.190B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.179B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.167B | 80.00 |
Quipt Home Medical (QIPT) | United States | $0.145B | 0.00 |
InterCure (INCR) | Israel | $0.143B | 24.19 |
Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
FitLife Brands (FTLF) | United States | $0.129B | 18.29 |
Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
Fonar (FONR) | United States | $0.099B | 8.54 |
MariMed (MRMD) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
Brainsway (BWAY) | Israel | $0.090B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.087B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
Safety Shot (SHOT) | United States | $0.074B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
Apyx Medical (APYX) | United States | $0.053B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
Bright Green (BGXX) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.043B | 15.62 |
Modular Medical (MODD) | United States | $0.038B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
Exagen (XGN) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |